Appia Bio
Biotechnology, 4955 Directors Place, San Diego, California, 92121, United States, 11-50 Employees
Who is APPIA BIO
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapie...
Read More
-
Headquarters: 4955 Directors Place, San Diego, California, 92121, United States
-
Date Founded: 2020
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Appia Bio Org Chart and Mapping
Email
Phone
Similar Companies to Appia Bio
Atara Biotherapeutics
-
201-500
-
$ 50 Million to 100 Million
Capsida Biotherapeutics
-
51-200
-
$ 1 Million to 5 Million
ImmPACT Bio
-
51-200
-
$ 25 Million to 50 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Appia Bio
Answer: Appia Bio's headquarters are located at 4955 Directors Place, San Diego, California, 92121, United States
Answer: Appia Bio's official website is https://appiabio.com
Answer: Appia Bio's revenue is $5 Million to $10 Million
Answer: Appia Bio's SIC: 2836
Answer: Appia Bio's NAICS: 541714
Answer: Appia Bio has 11-50 employees
Answer: Appia Bio is in Biotechnology
Answer: Appia Bio top competitors include: Atara Biotherapeutics , Capsida Biotherapeutics , ImmPACT Bio
Answer: Appia Bio contact info: Phone number: Website: https://appiabio.com
Answer: Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month